Edition:
United States

Johnson & Johnson (JNJ)

JNJ on New York Consolidated

135.31USD
21 Jul 2017
Change (% chg)

$-1.26 (-0.92%)
Prev Close
$136.57
Open
$135.33
Day's High
$136.27
Day's Low
$135.10
Volume
6,773,546
Avg. Vol
5,892,231
52-wk High
$137.08
52-wk Low
$109.32

Select another date:

BRIEF-EU Medicines Agency recommends approval J&J unit's Symtuza drug for HIV

* EU Medicines Agency recommends approval of Johnson & Johnson unit Janssen-Cilag International N.V. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (Symtuza) drug for HIV Source text ID: (http://bit.ly/2vIbPPG) Further company coverage:

UPDATE 2-China adds blockbuster drugs to insurance list after price cuts

* Gov't, drugmakers agreed price cuts of as much as 70 pct (Adds picture)

J&J sees sales growth in near-term; raises 2017 profit forecast

Johnson & Johnson said it expects sales growth to pick up in the second half of the year on strong demand for newer, pricey treatments such as cancer drugs Darzalex and Imbruvica.

UPDATE 5-J&J sees sales growth in near-term; raises 2017 profit forecast

* Pharmaceutical sales miss estimates for third straight qtr -RBC

CORRECTED-UPDATE 4-J&J sees sales growth in near-term; raises 2017 profit forecast

* Pharmaceutical sales miss estimates for third straight qtr - RBC

J&J reports dip in quarterly profit

July 18 Johnson & Johnson, which completed its $30 billion acquisition of Swiss biotech Actelion last month, reported a 4.3 percent fall in quarterly profit, as costs rose.

BRIEF-J&J sets quarterly cash dividend of $0.84 per share

* Sets quarterly cash dividend of $0.84 per share Source text for Eikon: Further company coverage:

Australian class action suit filed against Johnson & Johnson over pelvic mesh

SYDNEY Australian women have brought a class-action case against Johnson & Johnson over complications arising from vaginal mesh implants - a lawsuit that follows many others in the United States, Canada and Europe. | Video

Australian class action suit filed against Johnson & Johnson over pelvic mesh

SYDNEY, July 4 Australian women have brought a class-action case against Johnson & Johnson over complications arising from vaginal mesh implants - a lawsuit that follows many others in the United States, Canada and Europe.

Missouri attorney general sues opioid manufacturers

June 21 Missouri's attorney general on Wednesday announced a lawsuit against three major drug manufacturers claiming they fraudulently misrepresented the risks posed by opioid painkillers now at the center of a national addiction epidemic.

Select another date: